PRINT SCOPE


National Association of Testing Authorities, Australia

SCOPE OF ACCREDITATION



SA Pathology
FROME ROAD LABORATORY
| Accreditation Number: 2348 | Site Number: 2341 |

Address Details:
7 Frome Road
ADELAIDE, SA 5000
AUSTRALIA
Website: www.sapathology.sa.gov.au
Contact Details:
Mr Jason Graefling
+61(08) 82223137


Availability:Services available to external clients
Supervision:GY (General)



Note: Not all of the columns of the scope of accreditation displayed include data.
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.

 

Anatomical Pathology

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditionsCervical tissueReview and reporting of cervical cytological material; Cytological examination;
Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditionsVaginal tissueCytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples;
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancyOther body fluids; Sputum; Urine; Washings or brushings from other sites; Cytological examination; Review and reporting of cytology samples;
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changesAnus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Skin smears; Review and reporting of cytology samples; Cytological examination;
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsyFine needle aspirates (FNA)Review and reporting of fine needle aspiration samples; Cytological examination;
Anatomical pathology - Cytopathology - Testing for the National Cervical Screening ProgramLiquid based cytology specimens from cervixHuman papilloma virus; Cytological examination; Review and reporting of cervical cytological material;
Anatomical pathology - Tissue pathology - Examination of biopsy materialFormalin fixed tissue; Fresh tissue; Review and reporting of biopsy material to identify or exclude morphological abnormalities

Muscle and nerve only


Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopyFormalin fixed tissueReview and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities

Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigationFixed cytological smearsDetection of antigenic targets - Various
Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy)SemenVolume; Sperm number; Morphology; Motility;

Cellular Therapies Laboratory

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsBone marrow; Haemopoietic progenitor cells; Processing; Storage - Includes freezing/thawing;
Product received from Royal Adelaide Hospital Haematology Day Centre and WCH Apheresis Services



Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsHaemopoietic progenitor cellsEnumeration of CD34+ cells
Product received from Royal Adelaide Hospital Haematology Day Centre and WCH Apheresis Services




Cellular Therapies Laboratory

Complex Inherited Disorders

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Molecular genetics - Bioinformatic analysisDNA sequencesPrimary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation;
Molecular genetics - DNA sequencingBloodDNA sequence analysis

Cytogenetics (Cancer) Laboratory

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Cytogenetics - Detection of defined, unbalanced chromosomal abnormalities by in-situ hybridisation techniquesBlood; Bone marrow; Tissues; Cytogenetic analysis and reporting
Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalitiesBlood; Bone marrow; Tissues; Cytogenetic analysis and reporting
Cytogenetic analysis and reporting

Familial Cancer Laboratory

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Whole exome sequencing studies for inherited (germline) DNA/RNA changesBloodTEN Hamartoma tumour syndrome; Scwhannomatosis; Cowdens; Gastrointestinal stroma tumour; Paragangliomas; Von Hippel Lindau disease; Fanconi anaemia; Primary cilary dyskenesis; Retinoblastoma; Multiple endocrine neoplasia - Type 2 (MEN2); Immunodeficiency; Juvenile polyposis; Emberger syndrome; Renal clear cell carcinoma; Neurofibromatosis; Macrocephaly PTEN gene mutation; Familial adenomatous polyposis; Phaeochromocytoma; Acute myeloid leukaemia RUNX1; Bannayan-Riley-Ruvalcaba syndrome; Hereditary diffuse gastric cancer; Multiple endocrine neoplasia - Type 1 (MEN1); Hemangioblastoma; Lynch syndrome; Maturity onset diabetes of the young (MODY);
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changesAmniotic fluid; Blood; Buccal swabs; Chorionic villus; Renal clear cell carcinoma; Von Hippel Lindau disease; Scwhannomatosis; Hemangioblastoma; Bannayan-Riley-Ruvalcaba syndrome; TEN Hamartoma tumour syndrome; Retinoblastoma; Paragangliomas; Phaeochromocytoma; Lynch syndrome; Multiple endocrine neoplasia - Type 2 (MEN2); Hereditary diffuse gastric cancer; Cowdens; Neurofibromatosis; Familial adenomatous polyposis; Gastrointestinal stroma tumour; Multiple endocrine neoplasia - Type 1 (MEN1); Macrocephaly PTEN gene mutation; Acute myeloid leukaemia RUNX1; Emberger syndrome;

Immunology

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigationFormalin fixed paraffin embedded tissue sectionsDetection of antigenic targets - Various
Chemical pathology - Further investigation of renal and/or hepatic functionPlasma; Serum; Tryptase
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping)BloodHLA-DR1; HLA-DR4;
Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen; Fresh tissue; Lavage; Serous fluid; CD65; CD33; CD2; Immunoglobulin M (IgM); CD8; CD24; CD20; CD57; Immunoglobulin G (IgG); CD4; CD14; CD58; CD123; CD11c; CD10; T-cell receptor aβ (TCRab); CD7; CD38; CD27; CD41; CD19; CD61; CD25; CD45RA; Lambda light chains; CD34; CD235a; CD81; CD1a; CD11b; CD3; CD71; CD30; CD16; T-cell receptor (TCR) variable β; CD13; CD23; CD15; CD45; Kappa light chains; CD56; T-cell receptor γδ (TCRgd); CD45RO; CD64; CD28; CD117; CD138; HLA-DR antigen; CD103; CD22; FMC7; CD5; CD21; CD197;
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodiesPlasma; Serum; Anti-histone antibodies (AHA); Anti-intrinsic factor antibodies (IF);
Anti-nuclear antibodies (ANA); Anti-neutrophil cytoplasmic antibodies (ANCA);
Anti-soluble liver antigen/liver-pancreas antibodies (SLA/LP); Anti-liver cytosol antibodies (LC-1); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2);
Anti-glomerular basement membrane antibodies (anti-GBM); Anti-cardiolipin antibodies (ACA); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-thyroid peroxidase antibodies (TPO);
Anti-β-2-glycoprotein 1 antibodies
Anti-thyrotropin receptor antibodies (TSHR)
Anti-RNA polymerase III antibodies (ARA, RNAP)
Anti-Purkinje cell antibodies (PCA2); Anti-neuronal antibodies;
Anti-gastric parietal cell antibodies (GPC/PCA); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-smooth muscle antibodies (SMA); Anti-liver-kidney microsomes antibodies (LKM);
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens))SerumApi m1 phospholipase A2 - Honey bee; Ves v5 - Common wasp; Pol d5 - European paper wasp; β-Lactoglobulin - Milk; Ara h2 - Peanut;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens)SerumSuxamethonium (succinylcholine); Amoxicilloyl group; Ampicilloyl group; Cefaclor; Pholcodine; Penicilloyl G; Protamine; Penicilloyl V; Morphine;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens)SerumMouse urine proteins; Horse dander; Budgerigar droppings; Budgerigar feathers; Cat dander; Rabbit epithelium; Dog dander; Guinea pig epithelium; Rat urine proteins; Cow dander; Rat epithelium;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens)SerumGuar gum (E412)
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens)SerumEgg; Chicken; Egg white; Egg yolk;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens)SerumScallop; Pacific squid; Lobster; Blue mussel; Oyster; Codfish; Salmon; Shrimp; Tuna; Crab;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens)SerumOnion; Mandarin (tangerine, clementine, satsumas) citrus; Peach; Bromelain; Avocado; Watermelon; Banana; Potato; Apple; Melon; Apricot; Pineapple; Kiwi; Mango; Tomato; Orange citrus; Strawberry; Garlic;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens)SerumPork; Galactose-α-1,3-galactose; Beef; Mutton;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens)SerumCasein; Milk;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens)SerumChocolate; Yeasts; Cacao; Omega-5-gliadin;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens)SerumHazelnut; Maize; Lentil; Almond; Pinenut; Oat; Brazil nut; Macadamia nut; Wheat; Pistachio; Sesame seed; Rye; Rice; Pecan nut; Peanut; Lupin seed; Soy bean; Walnut; Cashew nut; Barley;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens)SerumMustard; Chilli pepper;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens)SerumBermuda grass; Bahia grass; Couch grass; Velvet grass; Rye grass; Profilin; Cultivated wheat; Brome grass; Timothy grass; Johnson grass;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens)SerumGerman cockroach; Mosquito;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens)SerumAspergillus flavus; Pityrosporum orbiculare; Aspergillus fumigatus; Setomelanomma rostrata (Helminthosporium halodes); Trichophyton rubrum; Aspergillus terreus; Alternaria alternata; Penicillium chrysogenum (formerly Penicillium notatum); Cladosporium herbarum; Malassezia spp.; Aspergillus niger;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens)SerumTyrophagus putrescentiae storage mite; Dermatophagoides pteronyssinus house dust mite; Lepidoglyphus destructor storage mite; Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Glycyphagus domesticus storage mite;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens)SerumLatex; Isocyanate HDI (hexamethylene diisocyanate, 1,6-hexamethylene diisocyanate); Chlorhexidine; Formaldehyde/formalin; α-Amylase;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens)SerumMelaleuca; Eucalyptus; Willow salix; Olive; Australian pine; White pine; Plane tree; Wattle; Silver birch; Acacia;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens)SerumBull ant - Myrmecia forficata; Bull ant - Myrmecia nigriceps; Jumper ant; Paper wasp venom; Common wasp (yellow jacket) venom; Bull ant - Myrmecia pyriformis; Honey bee venom;
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens)SerumRussian thistle; Saltwort (prickly); Sheep sorrel; Lamb’s quarters; Goosefoot; Plantain - English; Chenopodium; Wall pellitory;
Immunopathology - Quantitative and/or qualitative investigation of proteinsSerumProtein classes
Plasma; Serum; Characterisation of paraproteins; Detection and amount of paraproteins;
Detection and quantitation of free kappa and lambda light chains
FaecesCalprotectin
UrineDetection of Bence Jones proteins
Cryoglobulins; Cryofibrinogen; Characterisation of cryoglobulins;
Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclassesPlasma; Serum; Total immunoglobulin A
Total immunoglobulin G
Total immunoglobulin E
Immunopathology - Single HLA antigen typingBloodHLA-B27
HLA-B5701
Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulationBloodMycobacterial antigen lymphocyte stimulation
Molecular genetics - Screening for an unknown mutation - Targeted genesBloodThiopurine methyltransferase (TPMT) genotyping
Coeliac disease

Leukaemia Unit

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genesBlood; Bone marrow; Quantitative calculation of p210 positive BCR/ABL1 transcripts; Leukaemic gene rearrangements; CSF3R and SETBP1 mutation test;

Metabolic Laboratory

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Chemical pathology - Analysis of calculusCalculiPhosphate; Oxalate; Calcium; Magnesium;
Chemical pathology - Detection and/or quantitation of tumour markersPlasma; Serum; β-2-Microglobulin (B2M)
Chemical pathology - Detection and/or quantitation of tumour markers - Testing for the National Bowel Cancer Screening ProgramFaecesBlood
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests)SerumInsulin-like growth factor 1 (IGF-1, somatomedin C); Growth hormone;
Plasma; Serum; Gastrin; Erythropoietin (EPO);
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemiaSerumLipoprotein subclasses
Chemical pathology - Further investigation of renal and/or hepatic functionSerumLactate dehydrogenase (LDH) isoenzymes; Alkaline phosphatase isoenzymes;
Haptoglobins; α-1-Antitrypsin; Caeruloplasmin;
α-1-Antitrypsin phenotype
Faecesα-1-Antitrypsin
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, lipid, renal, skeletal muscle and other profiles and metabolic studiesSerumAcid phosphatase
Angiotensin converting enzyme (ACE)
Plasma45 Calcium absorption
Blood; Plasma; Cholinesterase
Cerebrospinal fluid (CSF)Albumin
Chemical pathology - Investigation of malabsorption - Quantitation of solid tissue enzymesIntestinal tissueSucrase; Maltase; Lactase;
Chemical pathology - Quantitation of precursor and intermediary metabolitesUrineOxalate
Chemical pathology - Quantitation of vitaminsSerum1,25-Dihydroxyvitamin D
25-Hydroxyvitamin D
Ascorbic acid (vitamin C)
BloodPyridoxine (vitamin B6); Thiamine (vitamin B1);
Chemical pathology - Trace element analysisPlasma; Serum; Selenium; Chromium; Zinc; Aluminium; Magnesium; Copper; Cobalt;
BloodMercury; Manganese; Lead; Magnesium; Cadmium;
LiverCopper
Iron
UrineLead; Arsenic; Cobalt; Mercury; Zinc; Magnesium; Copper; Iodine; Thallium; Manganese; Cadmium; Chromium;
Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays)BloodGlucose-6-phosphate dehydrogenase (G6PD)
Immunopathology - Quantitative and/or qualitative investigation of proteinsOther body fluidsβ-2-Transferrin
Cerebrospinal fluid (CSF)Detection of oligoclonal bands
Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclassesCerebrospinal fluid (CSF)Total immunoglobulin G

Microbiology and Infectious Diseases

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Microbiology - Bacteriology - Detection of pathogenic bacteriaIsolatesLegionella pneumophila
Respiratory specimensLegionella pneumophila
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria)Genital swabs; Urine; Mycoplasma genitalium
Eye swabs; Genital swabs; Liquid based cytology specimens; Urine; Neisseria gonorrhoeae; Chlamydia trachomatis;
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria)Bacterial isolatesMycobacterium spp.
Bacterial isolates; Respiratory specimens; Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB;
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites)Genital swabs; Urine; Trichomonas vaginalis
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses)PlasmaHIV-1 RNA
Plasma; Serum; Hepatitis C viral RNA
Hepatitis B (HBV) DNA
Liquid based cytology specimensHuman papilloma virus
Microbiology - Molecular biology - Microbial genotypingPlasmaHIV-1 sequencing for drug resistance
Plasma; Serum; Hepatitis C (HCV) subtypes
Microbiology - Mycobacteriology - Detection and identification of mycobacteriaIsolatesMycobacteria antibiotic susceptibility
Mycobacteria identification
Mycobacteria antibiotic susceptibility
Mycobacteria antibiotic susceptibility
Mycobacteria identification
Blood; Bone marrow; Mycobacteria identification
Other body fluids; Respiratory specimens; Tissues; Mycobacteria identification
Other body fluids; Respiratory specimens; Tissues; Urine; Mycobacteria identification; Other pathogenic bacteria to genus level or species level;
Mycobacteria identification
UrineMycobacteria identification
Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elementsIsolatesYeast susceptibility; Fungi susceptibility;
Yeast susceptibility
Yeasts identification; Fungi identification;
Fungi identification; Yeasts identification;
BloodFungi identification; Yeasts identification;
Cerebrospinal fluid (CSF); Fluids; General swabs; Isolates; Nails; Respiratory specimens; Skin scrapings; Tissues; Fungi identification; Yeasts identification;
Cerebrospinal fluid (CSF); Fluids; General swabs; Nails; Respiratory specimens; Skin scrapings; Tissues; Fungi identification; Yeasts identification;
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationPlasma; Serum; HTLV I/II; HIV 1/2 antibodies; Hepatitis C (HCV); HIV 1/2 antigen;

Molecular Genetics

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genesBloodAutoimmune polyendocrinopathy syndrome - Type 1; Haemophilia C; Von Willebrand disorder; Haemochromatosis; Haemophilia A; Haemophilia B; β-Thalassaemia (β-thalassemia); Factor V Leiden; Factor XIII deficiency; Alpha-thalassaemia; Prothrombin variant;
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genesBloodCopy number variation (CNV) chimerism test; Quantitation of donor and recipient bone marrow derived cells in a transplant recipient;
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changesFormalin fixed paraffin embedded tissue sectionsSingle nucleotide variants (SNVs); Indels;
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Whole exome sequencing for non-inherited (somatic) DNA/RNA changesBloodNovel isoforms; Indels; Fusion genes; Single nucleotide variants (SNVs);
Molecular genetics - Heterozygous loci determinationsBlood; Chorionic villus; Products of conception (POC); Tissues; Nucleic acid analysis for specific variants
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changesBloodIndels; Copy number variation (CNV); Single nucleotide variants (SNVs);
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changesBloodCopy number variation (CNV); Indels; Single nucleotide variants (SNVs);
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changesBloodβ-Thalassaemia (β-thalassemia); Haemophilia B; Haemophilia C; Alpha-thalassaemia; Haemophilia A;
Haemophilia C; Haemophilia B; Haemophilia A;
Molecular genetics - Prenatal genetic testing (excluding non-invasive prenatal [genetic] screening)Amniotic fluid; Chorionic villus tissue; Cultured amniotic fluid cells; Cultured chorionic villus cells; Alpha-thalassaemia; β-Thalassaemia (β-thalassemia); Haemophilia B; Haemophilia A;

Molecular Oncology

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genesBlood; Bone marrow; Formalin fixed paraffin embedded tissue sections; Solid tumours; Breast cancer; Blood borne tumours;
Molecular genetics - Heterozygous loci determinationsBlood; Tissues; Blood borne tumours

Paediatric Laboratory

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoringSerumSulthiame; Itraconazole; Posaconazole; Voriconazole;
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests)Serum17α-Hydroxyprogesterone 
Chemical pathology - Investigation of porphyriaBlood; Plasma cells; Total porphyrins
Faeces; Urine; Total porphyrins; Porphyrin isomers;
Urine δ-Aminolevulinic acid (δ-ALA); Porphobilinogen (PBG);
Chemical pathology - Quantitation of vitaminsSerumCarotenoids; Retinol (vitamin A); Tocopherol (vitamin E);

Sequencing Centre

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Molecular genetics - DNA sequencingPurified PCR productDNA sequence analysis

Toxicology Laboratory

ISO 15189 (2012)
Human Pathology
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicalsUrineEthyl sulfate; Ethylglucuronide (ETG);

ISO 15189 (2012)
Legal
SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
Medico legal drug testing AS 4760, section 4 Laboratory initial testingOral fluidAmphetamine type substances; Cocaine metabolites; Cocaine; δ-9-Tetrahydrocannabinol (THC);
Medico legal drug testing AS 4760, section 5 Confirmatory testing proceduresOral fluidBenzoylecgonine (ecgonine benzoate); Midazolam; 3,4-Methylenedioxyamphetamine (MDA); Methadone; Cocaine; Buprenorphine; Nordiazepam; Methyl amphetamine; Alprazolam; Codeine; Diazepam; Morphine; δ-9-Tetrahydrocannabinol (THC); Oxazepam; Flunitrazepam; Lorazepam; Oxycodone; 3,4-Methylenedioxymethamphetamine (MDMA); Ecgonine methyl ester; 6-Acetylmorphine; Temazepam; Clonazepam; Nitrazepam; Amphetamines;
Medico legal drug testing AS/NZS 4308, section 2 Specimen collection, storage, handling and dispatchUrinepH; Temperature; Colour; Creatinine;
Various Collection Centres



Medico legal drug testing AS/NZS 4308, section 3 General laboratory requirementsUrineGeneral laboratory requirements as described in AS/NZS 4308
Medico legal drug testing AS/NZS 4308, section 4 Laboratory screening proceduresUrineCocaine metabolites; Benzodiazepines; Amphetamine type substances; Cannabis metabolites; Opiates;
Medico legal drug testing AS/NZS 4308, section 5 Laboratory confirmatory proceduresUrineMethylenedioxymethylamphetamine; Methadone; Oxazepam; Nordiazepam; 7-Amino-nitrazepam; Amphetamines; Morphine; Buprenorphine; Methylenedioxyamphetamine; Ephedrine; Temazepam; Benzoylecgonine (ecgonine benzoate); Benzylpiperazine (BZP, 1-benzylpiperazine); 6-Acetylmorphine; Methyl amphetamine; Ecgonine methyl ester; Pseudoephedrine (PSE); Codeine; 7-Amino-flunitrazepam; 7-Amino-clonazepam; 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; α-Hydroxy-alprazolam; Phentermine; Diazepam;
| Accreditation Number: 2348 | Site Number: 2341 | Printed on : 17-Oct-2019

 

--------------------- END OF SCOPE ----------------------